Integrated

Transcend Therapeutics, Inc., established in 1992 in Waltham, Massachusetts, is a clinical-stage company focused on developing pharmaceuticals to address diseases associated with oxidative stress and tissue damage. The company also specializes in creating psychoactive medicines aimed at treating neuropsychiatric disorders. By targeting specific areas of the brain involved in the pathophysiology of these conditions, Transcend Therapeutics aims to enable healthcare providers to facilitate positive changes in brain function and behavior for their patients.

BrainSpace collaborates with physicians, families, financial backers, and other parties with the purpose of eliminating the long-term handicap brought on by brain injury.

Homecoming is a provider of patient engagement tools specifically designed for psychedelic therapy. The company has developed a digital companion application that supports patients throughout their therapeutic process. This application promotes accountability and fosters long-term change by offering personalized guides, tasks, and daily check-ins. Additionally, it provides preparation and integration support within a single, user-friendly platform that includes relevant patient program content. This enables healthcare professionals to effectively guide their patients on their healing journeys, enhancing the therapeutic experience and outcomes.

Founded in 2018, Wellset operates an online platform that connects users with wellness practitioners. It offers a wide range of services including mental health classes, stretching exercises, self-hypnosis, functional medicine, breathwork, EFT tapping, guided journaling, and meditation.

Founded in 2014, Beckley Psytech is a UK-based company dedicated to developing psychedelic medicines for treating mental health disorders. It focuses on rigorous scientific research and clinical-stage drug development, aiming to provide innovative treatments for conditions like depression and anxiety.

MycoMedica Life Sciences, founded by prominent mycologist Paul Stamets, is a life sciences company focused on developing therapeutic drugs derived from fungi to enhance human health. The company specializes in exploring the healing potential of the fungal genome, particularly in relation to psychiatric and neurological disorders. One of its key innovations, the Stamets Stack, combines unique ingredients not typically found together in nature to maximize the effectiveness of psilocybin for prevention and treatment. By studying various fungal species and their applications, MycoMedica aims to advance fungi-based drug development, ultimately benefiting both individuals and the planet.

Small Pharma Ltd. is a pharmaceutical company based in London, United Kingdom, founded in 2015. The company specializes in developing a rapid-acting antidepressant aimed at treating patients with depression. Small Pharma employs a scalable model of outsourced drug development, leveraging expert intellectual property design to facilitate the transition from academic discovery to commercial products. By assembling specialized teams with proven expertise across essential development disciplines, Small Pharma aims to effectively execute its drug development programs.

Founded in 2014, Beckley Psytech is a UK-based company dedicated to developing psychedelic medicines for treating mental health disorders. It focuses on rigorous scientific research and clinical-stage drug development, aiming to provide innovative treatments for conditions like depression and anxiety.